Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Drugs@FDA: FDA-approved drug database checked for 5-Amino-1MQ on July 30, 2026
SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERR, ERR, ERR), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an exercise mimetic. It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance
Unveiling the importance of B12 injection sites in maximizing benefits and understanding potential drawbacks
AOD-9604 demonstrates particular effectiveness in targeting visceral adipose tissue (deep abdominal fat) and abdominal subcutaneous fat
It aids your digestion, helps you to regulate mood, and assists in maintaining a healthy immune system
Stubborn Fat Deposits and Receptor Distribution Certain fat deposits are notoriously resistant to mobilization through diet and exercise alone
US$ 25.25
US$ 21.05
US$ 21.66
US$ 26.15
US$ 28.70
US$ 28.41
US$ 29.11
US$ 21.14
US$ 22.18
US$ 21.81
US$ 26.95
US$ 26.51
US$ 20.30
US$ 24.77
US$ 24.32
US$ 19.99
